Aravive, Inc.赞助的临床试验
总计35393个结果
-
Versartis Inc.终止
-
Carevive Systems, Inc.招聘中
-
Versartis Inc.Premier Research Group plc终止成人生长激素缺乏症 (AGHD)
-
Versartis Inc.Premier Research Group plc完全的
-
University of OklahomaEMD Serono; Aravive, Inc.主动,不招人
-
Carevive Systems, Inc.招聘中
-
Carevive Systems, Inc.完全的
-
Washington University School of MedicineAravive, Inc.撤销输卵管癌 | 上皮性卵巢癌 | 原发性腹膜癌
-
M.D. Anderson Cancer CenterAstraZeneca; Aravive Biologics Inc主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类耐药卵巢癌 | 难治性卵巢癌 | 难治性输卵管癌 | 难治性原发性腹膜癌美国
-
Nanodropper, Inc.Aravind Eye Care System完全的
-
Washington University School of MedicineNational Cancer Institute (NCI); Aravive, Inc.尚未招聘
-
Aravive, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)终止铂耐药卵巢癌美国, 西班牙, 比利时, 加拿大, 乔治亚州, 捷克语, 中国, 波兰, 法国, 英国, 意大利
-
University of AlbertaRevive Wellness Inc.招聘中
-
Palo Alto Veterans Institute for ResearchCarevive Systems, Inc.完全的
-
University of Alabama at BirminghamAmerican Cancer Society, Inc.; Carevive Systems, Inc.完全的
-
University of AlbertaMitacs; Canadian Foundation for Dietetic Research (CFDR); Revive Wellness Inc.完全的
-
Johns Hopkins UniversityAravind Eye Care System; PlenOptika完全的
-
University of Wisconsin, MadisonRevive Therapeutics, Ltd.招聘中
-
University of California, San FranciscoAravind Eye Hospitals, India终止
-
University of California, San FranciscoAravind Eye Hospitals, India完全的
-
University of California, San FranciscoAravind Eye Hospitals, India未知
-
University of California, San FranciscoAravind Eye Hospitals, India完全的